𝔖 Bobbio Scriptorium
✦   LIBER   ✦

An explanation of the variable clinical response to interleukin 2 and LAK cells

✍ Scribed by Giorgio Parmiani

Publisher
Elsevier Science
Year
1990
Tongue
English
Weight
830 KB
Volume
11
Category
Article
ISSN
0167-5699

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The mitogenic response of T cells to int
The mitogenic response of T cells to interleukin-2 requires Raf-1
✍ Detlev Riedel; Ulrich Brennscheidt; Michael Kiehntopf; Marion Brach; Friedhelm H πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 790 KB

The mitogenic response of T cells to interleukin-2 requires Raf-l\* The product of the c-raf-1 proto-oncogene, Raf-1, is known to encode a 74-kDa ubiquitously expressed cytoplasmic serinehhreonine kinase. Various growth factors such as epidermal growth factor, acidic fibroblast growth factor, plate

Lack of correlation between peripheral b
Lack of correlation between peripheral blood lymphokine-activated killer (lak) cell function and clinical response in patients with advanced malignant melanoma receiving recombinant interleukin 2
✍ A. K. Ghosh; H. Dazzi; N. Thatcher; M. Moore πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 French βš– 634 KB

A phase-1/11 study of recombinant interleukin 2 (rll-2) was performed in 31 melanoma patients. The first dose of rlL-2 was given intrasplenically followed 4 hr later by an i.v. dose and 3 further i.v. doses on alternate days. Three courses of treatment were planned at 3-week intervals. The maximum t